Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Status:
Terminated

Trial end date:
2019-08-29

Target enrollment:

Participant gender:

Evaluate the safety and tolerability of AMG 397. Estimate the maximum tolerated doses (MTDs) and/or biologically active doses.

Phase 1

Amgen

Azacitidine
Dexamethasone